Calumet Specialty Products Partners, L.P (CLMT) Reaches $4.18 After 4.00% Down Move; Carl Domino Has Decreased Johnson & Johnson (JNJ) Position By $809,370

July 12, 2017 - By Linda Rogers

The stock of Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) is a huge mover today! About 102,485 shares traded. Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) has risen 20.88% since July 12, 2016 and is uptrending. It has outperformed by 4.18% the S&P500.The move comes after 6 months negative chart setup for the $324.05 million company. It was reported on Jul, 12 by Barchart.com. We have $4.01 PT which if reached, will make NASDAQ:CLMT worth $12.96 million less.

Carl Domino Inc decreased Johnson & Johnson (JNJ) stake by 73.06% reported in 2016Q4 SEC filing. Carl Domino Inc sold 7,038 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Carl Domino Inc holds 2,595 shares with $299,000 value, down from 9,633 last quarter. Johnson & Johnson now has $354.86 billion valuation. The stock rose 0.62% or $0.82 reaching $132.05. About 1.82 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since July 12, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Since February 28, 2017, it had 2 buys, and 0 sales for $92,822 activity. 20,000 shares were bought by Go Timothy, worth $78,800 on Tuesday, February 28. Another trade for 3,600 shares valued at $14,022 was made by Mawer Stephen P on Tuesday, March 7.

Calumet Specialty Products Partners, L.P. is a producer of specialty hydrocarbon products in North America. The company has market cap of $324.05 million. The Firm operates through three divisions: specialty products, fuel products and oilfield services. It currently has negative earnings. In its specialty products segment, the Company processes crude oil and other feedstocks into a range of customized lubricating oils, white mineral oils, solvents, petrolatums and waxes.

Investors sentiment decreased to 1.03 in Q4 2016. Its down 0.19, from 1.22 in 2016Q3. It dived, as 17 investors sold Calumet Specialty Products Partners, L.P shares while 16 reduced holdings. 8 funds opened positions while 26 raised stakes. 8.38 million shares or 25.58% more from 6.67 million shares in 2016Q3 were reported. Moreover, Kcg Hldgs has 0.01% invested in Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) for 53,127 shares. Susquehanna Intll Grp Llp has invested 0% in Calumet Specialty Products Partners, L.P (NASDAQ:CLMT). New York-based Jefferies Grp Limited Liability Corp has invested 0% in Calumet Specialty Products Partners, L.P (NASDAQ:CLMT). Pnc Fincl Service Gp, a Pennsylvania-based fund reported 25,000 shares. Ameriprise Inc holds 209,680 shares. Ftb, a Tennessee-based fund reported 500 shares. Moreover, Morgan Stanley has 0% invested in Calumet Specialty Products Partners, L.P (NASDAQ:CLMT). Creative Planning has 45,806 shares for 0% of their portfolio. Moreover, Raymond James Fin Services Advsr has 0% invested in Calumet Specialty Products Partners, L.P (NASDAQ:CLMT). Tower Rech Cap Lc (Trc) owns 5,687 shares. Natl Bank Of America De owns 413,480 shares. Van Eck Assocs Corporation stated it has 0% of its portfolio in Calumet Specialty Products Partners, L.P (NASDAQ:CLMT). Citadel Advisors Limited Liability holds 38,026 shares. Oakwood Cap Ltd Ca holds 0.03% in Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) or 28,100 shares. Gradient Investments Ltd Limited Liability Company holds 0% or 20 shares.

Among 10 analysts covering Calumet Specialty Products Partners LP (NASDAQ:CLMT), 2 have Buy rating, 3 Sell and 5 Hold. Therefore 20% are positive. Calumet Specialty Products Partners LP had 23 analyst reports since August 6, 2015 according to SRatingsIntel. Credit Suisse downgraded Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) rating on Friday, February 19. Credit Suisse has “Neutral” rating and $18 target. The company was maintained on Thursday, February 18 by Cowen & Co. The rating was maintained by Credit Suisse with “Underperform” on Monday, April 25. Goldman Sachs initiated the shares of CLMT in report on Monday, November 23 with “Neutral” rating. The company was downgraded on Friday, March 24 by Credit Suisse. The stock of Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) has “Market Perform” rating given on Monday, April 18 by Wells Fargo. RBC Capital Markets maintained it with “Outperform” rating and $22 target in Thursday, February 18 report. The firm has “Underperform” rating by Raymond James given on Monday, April 18. As per Monday, April 11, the company rating was downgraded by Credit Suisse. DA Davidson initiated Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) rating on Monday, November 16. DA Davidson has “Buy” rating and $34 target.

Among 18 analysts covering Johnson & Johnson (NYSE:JNJ), 9 have Buy rating, 1 Sell and 8 Hold. Therefore 50% are positive. Johnson & Johnson had 47 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was upgraded by Deutsche Bank on Tuesday, September 29 to “Buy”. The rating was maintained by Goldman Sachs with “Neutral” on Wednesday, April 20. The firm earned “Sell” rating on Friday, May 20 by Standpoint Research. The firm earned “Outperform” rating on Wednesday, January 25 by RBC Capital Markets. The rating was maintained by Jefferies with “Hold” on Tuesday, June 14. S&P Research maintained the stock with “Buy” rating in Wednesday, October 14 report. Jefferies maintained it with “Hold” rating and $113 target in Thursday, July 14 report. As per Friday, June 16, the company rating was maintained by Jefferies. Cowen & Co maintained it with “Buy” rating and $14300 target in Tuesday, June 13 report. The firm has “Hold” rating by Jefferies given on Thursday, August 4.

Investors sentiment increased to 0.94 in Q4 2016. Its up 0.12, from 0.82 in 2016Q3. It increased, as 63 investors sold JNJ shares while 834 reduced holdings. 114 funds opened positions while 731 raised stakes. 1.72 billion shares or 0.88% more from 1.71 billion shares in 2016Q3 were reported. First Heartland Consultants reported 14,853 shares. Buckhead Mngmt Lc reported 113,652 shares or 2.48% of all its holdings. Noesis Capital Mangement Corp reported 12,885 shares. Capstone Invest Advsr Ltd stated it has 22,255 shares or 0.08% of all its holdings. Davy Asset Limited invested in 3.41% or 142,060 shares. Benedict Fincl has 53,216 shares for 3.54% of their portfolio. 11,035 are owned by Cna Financial. Bluemountain Capital Management Limited Com has 0.01% invested in Johnson & Johnson (NYSE:JNJ) for 3,615 shares. Rice Hall James And Associate Limited Liability Corp accumulated 36,960 shares. 8,825 are held by Psagot Invest House Limited. Tradewinds Cap Mgmt Limited Company invested in 0.56% or 7,354 shares. Foundry Prtn Lc reported 1.16% in Johnson & Johnson (NYSE:JNJ). Trust Of Oklahoma holds 0% or 8,337 shares. Commerzbank Aktiengesellschaft Fi invested in 651,026 shares. Old National Commercial Bank In accumulated 178,264 shares.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on July, 18. They expect $1.78 earnings per share, up 2.30% or $0.04 from last year’s $1.74 per share. JNJ’s profit will be $4.78B for 18.55 P/E if the $1.78 EPS becomes a reality. After $1.83 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -2.73% negative EPS growth.